Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized Patients

ANCA-related Vasculitis Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

Laboratory testing of Anti-Neutrophil Cytoplasm Antibody (ANCA) is used to confirm diagnosis of patients who have a high level of suspicion for ANCA-related vasculitis. In these patients the specificity and sensitivity to the ANCA test is very high. This study hopes to prove that when this lab test is performed on blood of patients who do not have a high level of suspicion for ANCA-related vasculitis, the sensitivity and specificity is reduced and there are many false positive results. Because of this, it should not be used as a screening test for a more general patient population.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• ANCA-related Vasculitis
• Vasculitis

• NCT number: NCT01238003
• Study type: Observational
• Source: Hillel Yaffe Medical Center
• Contact: Nina Avshovich, MD
• Phone: 972-52-5566049
• Email: ninaa@hy.health.gov.il
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 2010
• Completion date: December 2011